The Effect of Mild Renal Dysfunction on the Assessment of Plasma Amino Acid Concentration and Insulin Resistance in Patients with Type 2 Diabetes Mellitus

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Biguanide</td><td class="align_center">57 (61.3)</td></tr><tr><td class="align_left">Thiazolidine derivatives</td><td class="align_center">8 (8.6)</td></tr><tr><td class="align_left">Sulfonylurea</td><td class="align_center">19 (20.4)</td></tr><tr><td class="align_left">Glinide</td><td class="align_center">14 (15.1)</td></tr><tr><td class="align_left">Dipeptidyl peptidase 4 inhibitor</td><td class="align_center">73 (78.5)</td></tr><tr><td class="align_left"><i>α</i>-Glucosidase inhibitor</td><td class="align_center">27 (29.0)</td></tr><tr><td class="align_left">Sodium glucose cotransporter 2 inhibitor</td><td class="align_center">24 (25.8)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Values are presented as number (%).<br/></div></td></tr></table>

<div>Classification of medicine administered to patients with type 2 diabetes mellitus.</div>

Journal of Diabetes Research

tab2

Table 2

Table 2: The Effect of Mild Renal Dysfunction on the Assessment of Plasma Amino Acid Concentration and Insulin Resistance in Patients with Type 2 Diabetes Mellitus 

Table 2 | The Effect of Mild Renal Dysfunction on the Assessment of Plasma Amino Acid Concentration and Insulin Resistance in Patients with Type 2 Diabetes Mellitus 